Literature DB >> 18636665

Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy.

Dimitrios Velissaris1, Menelaos Karanikolas, Andreas Kalogeropoulos, Ekaterini Solomou, Panagiotis Polychronopoulos, Konstantinos Thomopoulos, Chrissoula Labropoulou-Karatza.   

Abstract

AIM: To analyze pituitary hormone and melatonin circadian rhythms, and to correlate hormonal alterations with clinical performance, hepatic disease severity and diagnostic tests used for the detection of hepatic encephalopathy in cirrhosis.
METHODS: Twenty-six patients with cirrhosis were enrolled in the study. Thirteen patients hospitalized for systemic diseases not affecting the liver were included as controls. Liver disease severity was assessed by the Child-Pugh score. All patients underwent detailed neurological assessment, electroencephalogram (EEG), brain magnetic resonance imaging (MRI), assays of pituitary hormone, cortisol and melatonin, and complete blood chemistry evaluation.
RESULTS: Pituitary hormone and melatonin circadian patterns were altered in cirrhosis patients without clinical encephalopathy. Circadian hormone alterations were different in cirrhosis patients compared with controls. Although cortisol secretion was not altered in any patient with cirrhosis, the basal cortisol levels were low and correlated with EEG and brain MRI abnormalities. Melatonin was the only hormone associated with the severity of liver insufficiency.
CONCLUSION: Abnormal pituitary hormone and melatonin circadian patterns are present in cirrhosis before the development of hepatic encephalopathy. These abnormalities may be early indicators of impending hepatic encephalopathy. Factors affecting the human biologic clock at the early stages of liver insufficiency require further study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636665      PMCID: PMC2725381          DOI: 10.3748/wjg.14.4190

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

Authors:  D Häussinger; G Kircheis; R Fischer; F Schliess; S vom Dahl
Journal:  J Hepatol       Date:  2000-06       Impact factor: 25.083

2.  Melatonin.

Authors:  J Arendt
Journal:  BMJ       Date:  1996-05-18

3.  [Pituitary-gonadal hormonal evaluation in male patients with alcoholic liver cirrhosis].

Authors:  J Kolster; C Castro de Kolster; R Bustillos; I de Pool; M Pepe
Journal:  G E N       Date:  1990 Jul-Sep

Review 4.  Melatonin.

Authors:  J Arendt
Journal:  Clin Endocrinol (Oxf)       Date:  1988-08       Impact factor: 3.478

5.  Screening of subclinical hepatic encephalopathy.

Authors:  M Groeneweg; W Moerland; J C Quero; W C Hop; P F Krabbe; S W Schalm
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

Review 6.  Use of melatonin in the treatment of phase shift and sleep disorders.

Authors:  D J Skene; S W Lockley; J Arendt
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

7.  Disruption of the diurnal rhythm of plasma melatonin in cirrhosis.

Authors:  P E Steindl; B Finn; B Bendok; S Rothke; P C Zee; A T Blei
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

8.  Hepatic retinopathy: morphological features of retinal glial (Müller) cells accompanying hepatic failure.

Authors:  A Reichenbach; U Fuchs; M Kasper; E el-Hifnawi; A K Eckstein
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Green light attenuates melatonin output and sleepiness during sleep deprivation.

Authors:  J A Horne; J Donlon; J Arendt
Journal:  Sleep       Date:  1991-06       Impact factor: 5.849

10.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

View more
  14 in total

1.  Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Authors:  Nan Wu; Fanyin Meng; Tianhao Zhou; Yuyan Han; Lindsey Kennedy; Julie Venter; Heather Francis; Sharon DeMorrow; Paolo Onori; Pietro Invernizzi; Francesca Bernuzzi; Romina Mancinelli; Eugenio Gaudio; Antonio Franchitto; Shannon Glaser; Gianfranco Alpini
Journal:  FASEB J       Date:  2017-06-20       Impact factor: 5.191

2.  Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.

Authors:  Anastasia Renzi; Shannon Glaser; Sharon Demorrow; Romina Mancinelli; Fanyin Meng; Antonio Franchitto; Julie Venter; Mellanie White; Heather Francis; Yuyan Han; Domenico Alvaro; Eugenio Gaudio; Guido Carpino; Yoshiyuki Ueno; Paolo Onori; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-14       Impact factor: 4.052

3.  Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver.

Authors:  Roni Atalay; Reyhan Ersoy; Aylin Bolat Demirezer; Fatma Ebru Akın; Sefika Burcak Polat; Bekir Cakir; Osman Ersoy
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

4.  Modification of sleep architecture in an animal model of experimental cirrhosis.

Authors:  Anabel Jiménez-Anguiano; Vanessa Díaz-Medina; Blanca-Eugenia Farfán-Labonne; Gloria Giono-Chiang; David Kersenobich; Mario García-Lorenzana; Maria Concepción Gutiérrez-Ruiz; Javier Velázquez-Moctezuma
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

5.  Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.

Authors:  Yuyan Han; Paolo Onori; Fanyin Meng; Sharon DeMorrow; Julie Venter; Heather Francis; Antonio Franchitto; Debolina Ray; Lindsey Kennedy; John Greene; Anastasia Renzi; Romina Mancinelli; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-11       Impact factor: 4.052

6.  Correlation of Serum Prolactin Level to Child Pugh Scoring System in Cirrhosis of Liver.

Authors:  Chaitanya H Balakrishnan; H Rajeev
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 7.  Melatonin regulation of biliary functions.

Authors:  Shannon Glaser; Yuyan Han; Heather Francis; Gianfranco Alpini
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

8.  Chronotypology and melatonin alterations in minimal hepatic encephalopathy.

Authors:  Dimitrios Velissaris; Vasilis Karamouzos; Panagiotis Polychronopoulos; Menelaos Karanikolas
Journal:  J Circadian Rhythms       Date:  2009-05-29

9.  Serum prolactin in patients with liver disease in comparison with healthy adults: A preliminary cross-sectional study.

Authors:  Sumit Kant Jha; Sridharan Kannan
Journal:  Int J Appl Basic Med Res       Date:  2016 Jan-Mar

Review 10.  Assessment and Management of Sleep Disturbance in Cirrhosis.

Authors:  Chiara Formentin; Maria Garrido; Sara Montagnese
Journal:  Curr Hepatol Rep       Date:  2018-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.